Osstem Implant’s Acquisition of Implacil de Bortoli

Following its acquisition by the MBK Partners–UCK Partners consortium in 2023, Osstem Implant has been actively pursuing a strategic growth plan to strengthen its global competitiveness. The aging population, rising demand for dental implants, and the rapid digitalization of dental care have further underscored the need for expanding overseas production and sales platforms. In particular, the South American market — including Brazil — has been recognized as a rapidly growing dental services market and a strategically important region for Osstem’s global expansion.

Against this backdrop, Implacil de Bortoli (“Implacil”), a leading dental implant manufacturer in Brazil, proved to be highly aligned with Osstem Implant’s global expansion strategy. Through this acquisition, Osstem Implant secured a strong foothold in the South American market and is expected to benefit from enhanced global supply chain diversification and a strengthened product portfolio.

PwC Korea and PwC Brazil’s Corporate Finance teams provided end to end Cross Border M&A advisory services, covering target screening support, industry and market analysis, acquisition strategy development, deal negotiations, and execution. In particular, the team closely monitored the competitive dynamics and the moves of other potential bidders, enabling Osstem Implant to position itself advantageously amid a competitive bidding environment. As a result, Osstem Implant successfully acquired Implacil on highly favorable terms despite the presence of multiple bidders.

This transaction was led by Partner Daeho Kang, with strong collaboration within PwC’s network, delivering an integrated and highly professional advisory service throughout the acquisition process.